Hungary – Various medicinal products – Új, tételes elszámolású hatóanyagok beszerzése
Description
The procurement of active substances subject to accounting, within the framework of an open procedure according to point a) of paragraph 1 of Article 105 of the Public Procurement Act, with the possibility of extending the active period of the Framework Agreement.
Subject of the current procurement procedure (in parts):
1. Part: Dupilumab for children (OENO: 06126)
Base quantity: 715 200 mg
Optional quantity: 238 400 mg
Minimum mandatory product discount quantity with respect to the base quantity: 1 200 mg
Minimum mandatory product discount quantity with respect to the optional quantity: 400 mg
2. Part: Dupilumab for adults (OENO: 06126)
Base quantity: 23 493 600 mg
Optional quantity: 7 831 200 mg
Minimum mandatory product discount quantity with respect to the base quantity: 1 800 mg
Minimum mandatory product discount quantity with respect to the optional quantity: 600 mg
3. Part: Mirikizumab (OENO: 06101)
Base quantity: 1 009 800 mg
Optional quantity: 336 600 mg
Minimum mandatory product discount quantity with respect to the base quantity: 600 mg
Minimum mandatory product discount quantity with respect to the optional quantity: 200 mg
4. Part: Pirtobrutinib (OENO: 06123)
Base quantity: 5 930 400 mg
Optional quantity: 1 976 800 mg
Minimum mandatory product discount quantity with respect to the base quantity: 8 400 mg
Minimum mandatory product discount quantity with respect to the optional quantity: 2 800 mg
5. Part: Blinatumomab (OENO: 06106)
Base quantity: 4 320 amp
Optional quantity: 1 440 amp
Minimum mandatory product discount quantity with respect to the base quantity: 3 amp
Minimum mandatory product discount quantity with respect to the optional quantity: 1 amp
6. Part: Serplulimab (OENO: 06118)
Base quantity: 195 000 mg
Optional quantity: 65 000 mg
Minimum mandatory product discount quantity with respect to the base quantity: 300 mg
Minimum mandatory product discount quantity with respect to the optional quantity: 100 mg
The contracting authority draws the attention of economic operators to the fact that in each part, pursuant to point j) of paragraph 1 of Article 73 of the Public Procurement Act, any tender containing a higher total tender price than the net wholesale price of the lowest-priced medicinal product containing the given active substance, offered by the tenderer in the given part, listed in the PUPHA register on the date of the tender, multiplied by the mg (in the case of the 5th part, ampoule) unit price and the total framework quantity, is invalid.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Hungary – Material for surgical sutures – Szemészeti anyagok beszerzése / 2026.
Somogy Vármegyei Kaposi Mór Oktató KórházHungaryMaterial for surgical suturesEye care products and corrective lensesDeadline in 29 daysPublished on Nov 19, 2026
Hungary – Antihaemorrhagics – Vérzékenység-készítmények (efan.-alfa, emicizumab)
Nemzeti Egészségbiztosítási AlapkezelőHungaryAntihaemorrhagicsNo deadline givenPublished on Nov 19, 2026
Hungary – Otolaryngology implant – Fülimplantátum rendszerek beszerzése
Semmelweis EgyetemHungaryOtolaryngology implantDeadline in 26 daysPublished on Nov 18, 2026
Hungary – Various medicinal products – Tételes elszámolás alá eső új hatóanyagok
Nemzeti Egészségbiztosítási AlapkezelőHungaryVarious medicinal productsDeadline in 10 daysPublished on Nov 17, 2026